Myeloma Other
Chimeric antigen receptor (CAR) T-cell therapy for leukemia
应用嵌合抗原受体T细胞疗法治疗白血病
Cytotoxic T lymphocytes for leukemia and lymphoma
细胞毒性T淋巴细胞治疗白血病和淋巴瘤
Maximizing graft-versus-leukemia in allogeneic transplantation: Role of donor lymphocyte infusions
最大化异基因造血干细胞移植中的移植物抗白血病效应：供者淋巴细胞输注的作用
Junior faculty mentorship
初级医师的师生关系
Signs of a problematic mentor-mentee relationship
师生关系出现问题的信号
Midlife crisis: Transitioning from being a mentee to becoming a mentor
中年危机：从学生到导师的转变
Laboratory methods to detect antiphospholipid antibodies
实验室方法检测抗磷脂抗体
Monitoring target specific oral anticoagulants
靶向口服抗凝剂的监测
Interpreting global assays of hemostasis
凝血全套检测方法的解读
The genomic landscape of acute lymphoblastic leukemia in children and young adults
儿童和青壮年急性淋巴细胞白血病患者的基因组图谱研究
Clinically defining and managing high-risk pediatric patients with acute lymphocytic leukemia
高危儿童急性淋巴细胞白血病患者的临床界定和管理
Balancing cure and long-term risks in childhood acute lymphoblastic leukemia
儿童急性淋巴细胞白血病患者的治疗与长期风险之间的平衡
Defining minimal residual disease in acute myeloid leukemia: Which platforms are ready for “prime time”?
探查急性髓细胞白血病微小残留病灶：哪种检测平台将进入黄金时期？
Goals for chronic myeloid leukemia TK inhibitor treatment: How little disease is too much?
慢性髓细胞白血病酪氨酸激酶抑制剂治疗目标：小病从来不小
Detection and management of minimal residual disease in acute lymphoblastic leukemia
急性淋巴细胞白血病微小残留病灶的检测和管理策略
Biology of marrow failure: Role of microenvironment and niches
骨髓衰竭综合征的生物学机制：微环境和生态位的作用
Timing of allogeneic stem cell transplant for myelodysplastic syndromes and aplastic anemia
在骨髓增生异常综合征和再生障碍性贫血患者中异基因造血干细胞移植的治疗时机
Established and novel agents for myelodysplastic syndromes
用于骨髓增生异常综合征治疗的现有药物和新药
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis
MYD88在淋巴浆细胞淋巴瘤的诊断和发病机制中的作用
Mutations in chronic lymphocytic leukemia, and how they impact therapy choice: Focus on NOTCH1, SF3B1, and TP53
慢性淋巴细胞白血病相关突变及其对治疗选择的影响：集中讨论NOTCH1、SF3B1和TP53
B-cell receptor pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
B细胞受体信号通路抑制治疗慢性淋巴细胞白血病和淋巴浆细胞淋巴瘤
Bleeding complications of targeted oral anticoagulants: What is the risk?
靶向口服抗凝剂的出血并发症：风险如何？
The targeted oral anticoagulants: Practical considerations
靶向口服抗凝剂：实践中的思考
Reversal of the new oral anticoagulants
新型口服抗凝剂的逆转效应
Iron clad: Iron homeostasis and the diagnosis of hereditary iron overload
体内铁平衡和遗传性铁过载的诊断
Guidelines for quantifying iron overload
定量铁过载的指南
Iron age: Novel targets for iron overload
铁过载治疗的新靶点
The science behind the hypoxic niche of hematopoietic stem and progenitors
造血干细胞和祖细胞在缺氧环境背后的科学
Transfusion strategies in hematologic and non-hematologic disease
血液疾病和非血液疾病的输血策略
Bloodless medicine: What to do when you can't transfuse
免输血医学:在不能输血时你该做些什么
Replacing bad (f)actors: Hemophilia
置换不良因子: 血友病
Smoothing the crescent curve: Sickle cell disease
抹平新月曲线：镰状细胞病
HSCT gene therapy for severe combined immune deficiency
HSCT基因治疗严重联合免疫缺陷
Pulmonary hypertension in sickle cell disease: Diagnosis and management
镰状细胞贫血病患者肺动脉高压的诊断和治疗
Reproductive issues in sickle cell disease
镰状细胞贫血病患者的生育问题
Breakthrough: New guidance for silent cerebral ischemia and infarction in sickle cell disease
突破性进展：镰状细胞贫血病中无症状性脑缺血和梗死的新指南
Intermediate-risk acute myeloid leukemia therapy: Current and future
中危急性髓细胞白血病的治疗：现状与展望
Immunotherapy for acute leukemia
急性白血病的免疫治疗
Epigenetic targeting and personalized approaches for acute myeloid leukemia
急性髓细胞白血病的表观遗传学靶向治疗及个体化治疗策略
How does JAK2V617F contribute to pathogenesis of myeloproliferative neoplasms?
JAK2V617F突变导致骨髓增殖性肿瘤的机制
Therapy for myeloproliferative neoplasms: When, which agent, and how?
骨髓增殖性肿瘤治疗：治疗时机、治疗药物、治疗方案
The evolving genomic landscape of myeloproliferative neoplasms
骨髓增殖性肿瘤的基因研究进展
Anticoagulation: In vitro fertilization and ovarian stimulation
体外受精和卵巢刺激过程中的抗凝问题
Pregnancy and venous thromboembolism (VTE): “TIPPS” for risk stratification
妊娠与静脉血栓栓塞（VTE）：TIPPS风险分级
Anticoagulation in pregnancy complications
妊娠合并症与抗凝治疗
New insights into treatment of venous thromboembolism
静脉血栓栓塞的治疗新进展
Keeping the pipes open: Management of catheter-associated thrombosis
保持管路通畅：如何处理导管相关血栓
Prevention and treatment of venous thromboembolism in patients with cancer
肿瘤患者静脉血栓栓塞的预防和处置
Clinical and laboratory diagnosis of von Willebrand disease
血管性血友病的临床及实验室诊断
New insights into genotype and phenotype of von Willebrand disease
血管性血友病遗传型和表型的新见解
Management of von Willebrand disease
血管性血友病的管理
Recent insights into the role of the contact pathway in thrombo-inflammatory disorders
接触通路在血栓炎症性疾病中作用的最新见解
Epidemiologic and clinical data linking factors XI and XII to thrombosis
Ⅺ因子和Ⅻ因子与血栓形成之间的流行病学和临床数据
Future prospects for contact factors as therapeutic targets
接触因子作为治疗靶点的未来前景
Update in congenital platelet syndromes
先天性血小板综合征的最新报道
Pharmacogenomics of antiplatelet drugs
抗血小板药物的药物基因组学
Management of MPN beyond JAK2
基于JAK2基因突变进行骨髓增殖性肿瘤的处理
Geriatric perspective: How to assess fitness for chemotherapy in older adults with acute myeloid leukemia
老年学评估：如何评估急性髓细胞白血病老年患者化疗的适合性
Treating acute myeloid leukemia in older adults
急性髓细胞白血病老年患者的治疗
Allogeneic transplants in older patients with acute myeloid leukemia
急性髓细胞白血病老年患者的异基因移植治疗
Diagnosis: When and how, FISH vs. IHC
诊断：何时诊断以及如何诊断：荧光原位杂交法（FISH）与免疫组织化学法（IHC）的比较研究
Impact of MYC on malignant behavior
MYC基因对恶性行为的影响
Double hit lymphomas: Current paradigms and novel treatment approaches
二次打击淋巴瘤：当前治疗模式及新型治疗方法
Optimal disease surveillance strategies in non-Hodgkin lymphoma
非霍奇金淋巴瘤的最佳疾病监测策略
Current survivorship recommendations for patients with Hodgkin lymphoma: Focus on late effects
当前针对霍奇金淋巴瘤患者生存情况的推荐意见：聚焦晚期症状
Caring for the long-term survivor after allogeneic stem cell transplantation
关注异基因造血干细胞移植后患者的长期生存
Thrombotic microangiopathy and indications for therapeutic plasma exchange
血栓性微血管病与治疗性血浆置换的适应证
Red cell exchange: Exchanging cells to improve outcome
红细胞置换：细胞置换对预后的改善
Leukocytapheresis for the treatment of hyperleukocytosis secondary of acute leukemia
白细胞去除术用于治疗继发于急性白血病的白细胞过多症
The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
氟脱氧葡萄糖-正电子发射断层成像（FDG-PET）在早期霍奇金淋巴瘤疾病预后中的作用
The classical Hodgkin lymphoma tumor microenvironment: Macrophages and gene expression-based modeling
经典型霍奇金淋巴瘤微环境：基于巨噬细胞和基因表达建模
Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era
Brentuximab vedotin治疗复发性经典型霍奇金淋巴瘤
Platelets: More than a sack of glue
血小板：不仅仅是一袋胶
RBCs as targets of infection
作为感染靶标的RBCs
Flamethrowers: Blood cells and cancer thrombosis risk
血液细胞和癌症血栓形成的风险
Indolent lymphoma: Follicular lymphoma and the microenvironment—insights from the microscope
惰性淋巴瘤: 从显微镜透视滤泡淋巴瘤和微环境
Indolent lymphoma: Follicular lymphoma and the microenvironment—insights from gene expression profiling
惰性淋巴瘤: 从基因表达透视滤泡性淋巴瘤和微环境
Therapeutic targeting of microenvironment in follicular lymphoma
针对滤泡性淋巴瘤微环境的靶向治疗
All transplantation-eligible patients with myeloma should receive ASCT in first response
所有适合移植的骨髓瘤患者应该在第一次缓解时行ASCT
Early or delayed transplantation for multiple myeloma in the era of novel therapy: Does one size fit all?
在新药时代多发性骨髓瘤应早期移植还是延迟移植：可以一刀切吗？
A practical approach to relapsed multiple myeloma
复发性多发性骨髓瘤的一种治疗策略
Lasting power of new clotting proteins
新型凝血蛋白的持续效力
Risky business of inhibitors: Human leukocyte antigen haplotypes, gene polymorphisms, and immune responses
抑制物相关风险：人白细胞抗原单倍型、基因多态性及免疫反应
Tooling up the inhibitor toolbox: Optimal therapy for inhibitors
针对抑制物的治疗方案：抑制物最佳治疗策略
Screening for and management of hepatitis B reactivation in patients treated with anti-B-cell therapy
抗B细胞治疗后患者体内HBV病毒再活化的筛查和管理
Lymphoma and HIV infection: Five questions
淋巴瘤与HIV感染：五项问题
Hepatitis C virus-associated B-cell non-Hodgkin lymphoma
丙型肝炎病毒相关B细胞非霍奇金淋巴瘤
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis
MYD88在淋巴浆细胞淋巴瘤的诊断和发病机制中的作用
Mutations in chronic lymphocytic leukemia, and how they impact therapy choice: Focus on NOTCH1, SF3B1, and TP53
慢性淋巴细胞白血病相关突变及其对治疗选择的影响：集中讨论NOTCH1、SF3B1和TP53
B-cell receptor pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
B细胞受体信号通路抑制治疗慢性淋巴细胞白血病和淋巴浆细胞淋巴瘤
